Half Moon Bay, CA, United States of America

Nathan Guz

USPTO Granted Patents = 11 

 

Average Co-Inventor Count = 7.7

ph-index = 4

Forward Citations = 53(Granted Patents)


Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: Nathan Guz: Innovator in Cancer Treatment

Introduction

Nathan Guz is a prominent inventor based in Half Moon Bay, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel treatments for cancer. With a total of 10 patents to his name, Guz has established himself as a key figure in medical innovation.

Latest Patents

One of Guz's latest patents involves the crystalline solid forms of the chemical compound N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N'-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide. This invention relates to novel crystalline solid forms that are useful for the treatment of various types of cancer, including thyroid cancer, prostate cancer, hepatocellular cancer, renal cancer, and non-small cell lung carcinoma. The patent also discloses pharmaceutical compositions comprising these crystalline solid forms, along with processes for their production and methods of use.

Career Highlights

Throughout his career, Nathan Guz has worked with notable companies in the pharmaceutical industry, including Exelixis, Inc. and Genentech, Inc. His work has focused on developing innovative solutions that address critical health challenges, particularly in oncology.

Collaborations

Guz has collaborated with several talented individuals in his field, including Sriram Naganathan and Matthew Pfeiffer. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Nathan Guz is a dedicated inventor whose work has the potential to significantly impact cancer treatment. His innovative approaches and collaborations continue to drive advancements in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…